Starting December 2, Korea plans to limit the prescription of Wegovy through telemedicine - KBR
Pharma Executive States Bayer Patent Cliff Poses a Minor Challenge - BNN Bloomberg
China's state insurance list now includes AstraZeneca's Enhertu breast cancer medication - XM
Enhertu cancer medication from AstraZeneca included in China's healthcare coverage program, reports The Times
European Commission Penalizes Teva with Fine of €462.6 Million for Misusing EPO's Patent System